Following a groundbreaking court decision about out-of-province care and an about-face from Nova Scotia's premier, two women are still processing how their lives — and potentially thousands of others ...
Morreale’s fear was compounded by the rigidity of the most common approach to treating babies born after being exposed in the womb to opioids or some medications used to treat opioid addiction.
Illegal immigration: "The open border policies must stop now to ensure the safety and well-being of our country. These dangerous policies have allowed millions of unvetted people to flood our states ...
Migraine medications fall into two broad categories. When a migraine begins, you can turn to drugs that ease the pain (acute treatment). If you have recurrent or chronic migraines, you can take ...
The six meds involved are Gilead Sciences’ Yescarta and Tecartus, Bristol Myers Squibb’s Breyanzi and Abecma, Johnson & Johnson and Legend Biotech’s Carvykti, and Novartis’ Kymriah.
Dementia treatment is more than just medication. It can include lifestyle changes, multimodal therapy, and environmental management, as well. Your dementia treatment plan will depend on underlying ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University in ...
But advanced prostate cancer, which has spread beyond the prostate to other parts of the body, remains notoriously elusive and resourceful when it’s attacked, resisting surgery and drugs that ...
Net revenue from AbbVie’s line of neuroscience products, which includes Botox, the antipsychotic Vraylar and the migraine medication Ubrelvy, totaled $4.1 billion during the first six months of this ...
The apex drug regulator has found 49 medicines as sub-standard and four to be spurious in its monthly survey of drugs available in the market. The list contained commonly used medicines such as ...
The benefits of puberty-blocking drugs for transgender children are drawing fresh attention after the scientist leading a major federally funded study was quoted by The New York Times as saying ...